Specificity Inc. (OTCID:SPTY) confirmed that its S‑1 registration statement, filed on October 14, 2025, became effective on November 4, 2025, allowing the company to offer shares to investors under SEC rules and to transition from OTC alternative reporting to full SEC reporting.
The effective filing activates the company’s STRATA Agreement with an institutional investor, providing up to $5 million in equity financing. The agreement permits controlled timing, amounts, and pricing of capital raises, aiming to minimize dilution while giving Specificity immediate access to capital for product development, sales expansion, and working‑capital needs.
Prior to the S‑1 effectiveness, Specificity reported significant net losses and cash‑flow constraints. In Q3 2024, revenue fell compared to Q3 2023, and the company’s cash position was insufficient to sustain its growth plans. The new financing is intended to address these liquidity challenges and support the company’s expansion into new markets.
CEO Robert Fedder and CTO Rob Gagne emphasized that the capital will accelerate the development of the company’s proprietary ad‑tech platform, expand sales operations globally, and strengthen working capital to support ongoing product launches. They noted that the STRATA Agreement’s flexibility will allow Specificity to raise additional funds on favorable terms as needed.
The S‑1 effectiveness marks a significant milestone for Specificity, a fast‑scaling ad‑tech disruptor redefining digital marketing precision. The event removes the company’s alternative reporting status on OTC Markets and positions it for broader investor access and future capital raises.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.